A Practical Review of the Presentation, Diagnosis, and Management of Cutaneous B-Cell Lymphomas.

[1]  A. Satou,et al.  EBV‐positive B‐cell lymphomas and lymphoproliferative disorders: Review from the perspective of immune escape and immunodeficiency , 2021, Cancer medicine.

[2]  D. O’Leary,et al.  Assessing the diagnosis of "primary cutaneous mantle cell lymphoma": A systematic review and population-based analysis. , 2021, Journal of the American Academy of Dermatology.

[3]  T. Habermann,et al.  Outcomes in primary cutaneous diffuse large B‐cell lymphoma, leg type , 2021, Hematological oncology.

[4]  L. Cerroni,et al.  Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features. , 2021, Blood advances.

[5]  T. Molina,et al.  Dissociation of humoral and cellular immune responses in kidney transplant recipients with EBV mucocutaneous ulcer , 2020, Transplant infectious disease : an official journal of the Transplantation Society.

[6]  M. Krampera,et al.  Oncogenic Mutations of MYD88 and CD79B in Diffuse Large B-Cell Lymphoma and Implications for Clinical Practice , 2020, Cancers.

[7]  S. Swerdlow,et al.  How I Diagnose Primary Cutaneous Marginal Zone Lymphoma. , 2020, American journal of clinical pathology.

[8]  T. Yoshino,et al.  Clinicopathological analysis of 34 Japanese patients with EBV-positive mucocutaneous ulcer , 2020, Modern Pathology.

[9]  S. Swerdlow,et al.  Class-switched Primary Cutaneous Marginal Zone Lymphomas Are Frequently IgG4-positive and Have Features Distinct From IgM-positive Cases , 2019, The American journal of surgical pathology.

[10]  T. Yoshino,et al.  A review of EBV-positive mucocutaneous ulcers focusing on clinical and pathological aspects , 2019, Journal of clinical and experimental hematopathology : JCEH.

[11]  E. Jaffe,et al.  The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. , 2019, Blood.

[12]  Hiroki Kobayashi,et al.  Sensitivity and specificity of incisional random skin biopsy for diagnosis of intravascular large B-cell lymphoma. , 2019, Blood.

[13]  F. Hernandez-Ilizaliturri,et al.  Radiological imaging and bone marrow biopsy in staging of cutaneous B‐cell lymphoma , 2019, British journal of haematology.

[14]  K. Ohshima,et al.  [BCL2, BCL6, and MYC-positive intravascular large B-cell lymphoma presenting with bilateral adrenal gland lesions]. , 2019, [Rinsho ketsueki] The Japanese journal of clinical hematology.

[15]  L. Lipi,et al.  Skin involvement in Burkitt's lymphoma. , 2018, Hematology/Oncology and Stem Cell Therapy.

[16]  A. Hristov,et al.  Primary Cutaneous Follicle Center Lymphoma. , 2018, Archives of pathology & laboratory medicine.

[17]  R. Willemze,et al.  High Incidence and Clinical Significance of MYC Rearrangements in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type , 2018, The American journal of surgical pathology.

[18]  L. Cerroni,et al.  Genomic Analyses Identify Recurrent Alterations in Immune Evasion Genes in Diffuse Large B-Cell Lymphoma, Leg Type. , 2018, The Journal of investigative dermatology.

[19]  E. Campo,et al.  Intravascular large B-cell lymphoma: a chameleon with multiple faces and many masks. , 2018, Blood.

[20]  K. Bohjanen,et al.  Mortality in intravascular large B‐cell lymphoma: A SEER analysis , 2018, Journal of the American Academy of Dermatology.

[21]  A. Rosenwald,et al.  Panel Sequencing Shows Recurrent Genetic FAS Alterations in Primary Cutaneous Marginal Zone Lymphoma. , 2018, The Journal of investigative dermatology.

[22]  L. Quintanilla‐Martinez,et al.  EBV-Positive Lymphoproliferations of B- T- and NK-Cell Derivation in Non-Immunocompromised Hosts , 2018, Pathogens.

[23]  A. Ng,et al.  Very low‐dose versus standard dose radiation therapy for indolent primary cutaneous B‐cell lymphomas: A retrospective study , 2018, Journal of American Academy of Dermatology.

[24]  L. Cerroni,et al.  AL Amyloidoma of the Skin/Subcutis: Cutaneous Amyloidosis, Plasma Cell Dyscrasia or a Manifestation of Primary Cutaneous Marginal Zone Lymphoma? , 2017, The American journal of surgical pathology.

[25]  M. Feinmesser,et al.  Paediatric primary cutaneous marginal zone B‐cell lymphoma: does it differ from its adult counterpart? , 2017, The British journal of dermatology.

[26]  T. Petrella,et al.  Retrospective study of intravascular large B-cell lymphoma cases diagnosed in Quebec , 2017, Medicine.

[27]  Y. Natkunam,et al.  EBV-Positive B-Cell Proliferations of Varied Malignant Potential: 2015 SH/EAHP Workshop Report—Part 1 , 2017, American journal of clinical pathology.

[28]  N. Nishimura,et al.  Intravascular Large B-cell Lymphoma of the Bilateral Ovaries and Uterus in an Asymptomatic Patient with a t(11;22)(q23;q11) Constitutional Translocation , 2016, Internal medicine.

[29]  S. Horwitz,et al.  Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides , 2016, Current Hematologic Malignancy Reports.

[30]  J. Liao,et al.  Diagnostic and therapeutic challenges of EBV-positive mucocutaneous ulcer: a case report and systematic review of the literature , 2016, Experimental Hematology & Oncology.

[31]  M. Lima.  Cutaneous primary B-cell lymphomas: from diagnosis to treatment , 2015, Anais brasileiros de dermatologia.

[32]  E. Jaffe,et al.  The histological classification of diffuse large B-cell lymphomas. , 2015, Seminars in hematology.

[33]  L. Duncan,et al.  Atlas of Cutaneous Lymphomas , 2015 .

[34]  T. Petrella,et al.  High frequency and clinical prognostic value of MYD88 L265P mutation in primary cutaneous diffuse large B-cell lymphoma, leg-type. , 2014, JAMA dermatology.

[35]  O. Dereure,et al.  Improvement of survival in patients with primary cutaneous diffuse large B-cell lymphoma, leg type, in France. , 2014, JAMA dermatology.

[36]  S. Ikehara,et al.  Benefits of skin biopsy of senile hemangioma in intravascular large B-cell lymphoma: A case report and review of the literature , 2014, Oncology letters.

[37]  T. Petrella,et al.  Multiple genetic alterations in primary cutaneous large B-cell lymphoma, leg type support a common lymphomagenesis with activated B-cell-like diffuse large B-cell lymphoma , 2014, Modern Pathology.

[38]  C. Schmidt,et al.  Nuclear factor-κB pathway-activating gene aberrancies in primary cutaneous large B-cell lymphoma, leg type. , 2014, The Journal of investigative dermatology.

[39]  R. Gascoyne,et al.  Treatment and outcomes in patients with primary cutaneous B-cell lymphoma: the BC Cancer Agency experience. , 2013, International journal of radiation oncology, biology, physics.

[40]  S. Horwitz,et al.  Primary cutaneous B-cell lymphomas: part I. Clinical features, diagnosis, and classification. , 2013, Journal of the American Academy of Dermatology.

[41]  F. Climent,et al.  Primary cutaneous marginal zone B-cell lymphoma: Response to treatment and disease-free survival in a series of 137 patients , 2013 .

[42]  A. Soni,et al.  Hodgkin's lymphoma with cutaneous involvement , 2012, BMJ Case Reports.

[43]  D. Cappellen,et al.  MYD88 somatic mutation is a genetic feature of primary cutaneous diffuse large B-cell lymphoma, leg type. , 2012, The Journal of investigative dermatology.

[44]  F. Al-Mulla,et al.  Genotypic and Phenotypic Differences between Nodal and Extranodal Diffuse Large B-Cell Lymphomas , 2011, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[45]  Xiaoyan Zhou,et al.  FOXP1 expression and its clinicopathologic significance in nodal and extranodal diffuse large B-cell lymphoma , 2011, Annals of Hematology.

[46]  S. Swerdlow,et al.  Cutaneous Marginal Zone Lymphomas Have Distinctive Features and Include 2 Subsets , 2010, The American journal of surgical pathology.

[47]  S. Parker,et al.  Intralesional corticosteroid therapy for primary cutaneous B‐cell lymphoma , 2010, The British journal of dermatology.

[48]  E. Jaffe,et al.  EBV Positive Mucocutaneous Ulcer—A Study of 26 Cases Associated With Various Sources of Immunosuppression , 2010, The American journal of surgical pathology.

[49]  S. Devesa,et al.  Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. , 2009, Blood.

[50]  B. Dréno,et al.  Routine bone marrow biopsy in the initial evaluation of primary cutaneous B-cell lymphoma does not appear justified. , 2009, European journal of dermatology : EJD.

[51]  T. Petrella,et al.  Fine-mapping chromosomal loss at 9p21: correlation with prognosis in primary cutaneous diffuse large B-cell lymphoma, leg type. , 2009, The Journal of investigative dermatology.

[52]  R. Bende,et al.  The majority of cutaneous marginal zone B-cell lymphomas expresses class-switched immunoglobulins and develops in a T-helper type 2 inflammatory environment. , 2008, Blood.

[53]  Angelica Selim,et al.  TNM Classification System for Primary Cutaneous Lymphomas , 2008 .

[54]  S. Kimura,et al.  Use of random skin biopsy for diagnosis of intravascular large B-cell lymphoma. , 2007, Mayo Clinic proceedings.

[55]  R. Willemze,et al.  Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO-EORTC classification. , 2007, Archives of dermatology.

[56]  C. Missouris,et al.  Angiotropic lymphoma: Associated chromosomal abnormalities. , 2007, European journal of internal medicine.

[57]  E. Campo,et al.  Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[58]  T. Yoshino,et al.  Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5. , 2007, Blood.

[59]  A. Ferreri,et al.  Intravascular lymphoma: a neoplasm of ‘homeless’ lymphocytes? , 2006, Hematological oncology.

[60]  C. Meijer,et al.  Expression of B-cell transcription factors in primary cutaneous B-cell lymphoma , 2006, Modern Pathology.

[61]  G. Niedobitek,et al.  Primary cutaneous follicle center lymphoma and primary cutaneous large B-cell lymphoma, leg type, are both targeted by aberrant somatic hypermutation but demonstrate differential expression of AID. , 2006, Blood.

[62]  E. Jordanova,et al.  Array-based comparative genomic hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[63]  E. Noordijk,et al.  Primary cutaneous marginal zone B-cell lymphoma: clinical and therapeutic features in 50 cases. , 2005, Archives of dermatology.

[64]  Nicola Pimpinelli,et al.  WHO-EORTC classification for cutaneous lymphomas. , 2005, Blood.

[65]  Remco Dijkman,et al.  Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling. , 2005, Blood.

[66]  A. Chott,et al.  T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma , 2005, Leukemia.

[67]  A. López-Guillermo,et al.  Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’ 1 , 2004, British journal of haematology.

[68]  H. Kerl,et al.  [Primary cutaneous B-cell lymphomas]. , 2004, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[69]  S. Hata,et al.  Intravascular large B cell lymphoma diagnosed by senile angioma biopsy. , 2003, Internal medicine.

[70]  T. Suchi,et al.  An Asian variant of intravascular large B‐cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B‐cell lymphoma associated with haemophagocytic syndrome , 2000, British journal of haematology.

[71]  A. Ohkawara,et al.  A case of intravascular large B‐cell lymphoma mimicking erythema nodosum: the importance of multiple skin biopsies , 2000, Journal of cutaneous pathology.

[72]  H. Kerl,et al.  Cutaneous involvement in lymphoblastic lymphoma , 1999, Journal of cutaneous pathology.

[73]  C. Meijer,et al.  Treatment of multifocal primary cutaneous B-cell lymphoma: a clinical follow-up study of 29 patients. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[74]  T. Molina,et al.  Primary cutaneous large-cell lymphoma: analysis of 49 patients included in the LNH87 prospective trial of polychemotherapy for high-grade lymphomas , 1998, Leukemia.

[75]  H. Tilly,et al.  Primary cutaneous medium and large cell lymphomas other than mycosis fungoides. An immunohistological and follow‐up study on 54 cases , 1995, The British journal of dermatology.

[76]  P. Keown,et al.  Primary Acute Renal Failure (“Acute Tubular Necrosis”) in the Transplanted Kidney: Morphology and Pathogenesis , 1989, Medicine.